AbbVie Says Health Canada Issues Notice of Compliance for EPKINLY in Follicular Lymphoma

MT newswire2026/09/24 11:56

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

07:56 AM EDT, 09/24/2026 (MT Newswires) -- AbbVie (ABBV) said Thursday that Health Canada issued a Notice of Compliance for EPKINLY, or epcoritamab, for a new indication to treat adults with follicular lymphoma, a subtype of non-Hodgkin lymphoma. EPKINLY, in combination with lenalidomide and rituximab, is indicated to treat patients with relapsed or refractory Grade 1, 2, or 3a follicular lymphoma who have received at least one prior line of systemic therapy, the company said. AbbVie said the approval was supported by results from its phase 3 EPCORE FL-1 study, which showed that EPKINLY, in combination with lenalidomide and rituximab, reduced the risk of disease progression or death by 79% compared with lenalidomide and rituximab alone. AbbVie said it is developing EPKINLY with Genmab as part of an oncology collaboration.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Goldman Sachs believes that the rapid rise in real interest rates has exerted more direct pressure on the US stock market, with rate-sensitive sectors such as small-cap and financial stocks being particularly affected. On the liquidity front, Goldman Sachs estimates that pension funds may sell around $3.3 billions in equities at the end of the month and quarter, and that CTAs may sell about $530 million worth of Russell 2000 index futures in the coming week. For the market, unless the issues of oil and interest rates are resolved, the AI narrative is "almost irrelevant."

华尔街见闻•2026/09/30 04:01

USD/JPY falls below 157! The yen becomes the strongest G-10 currency, with the market betting on another rate hike by the central bank next month.

On Wednesday, the yen strengthened against the US dollar, with the USD/JPY rate falling below the 157 mark, as repeated warnings from the Japanese government regarding exchange rates and end-of-quarter capital flows provided support for the yen.

智通财经•2026/09/30 03:41